How were Ritter Pharmaceuticals' earnings last quarter?

Ritter Pharmaceuticals Inc (NASDAQ:RTTR) issued its quarterly earnings data on Friday, May, 1st. The biotechnology company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.04) by $0.01.

When did Ritter Pharmaceuticals' stock split?

Ritter Pharmaceuticals shares reverse split on the morning of Friday, March 23rd 2018. The 1-10 reverse split was announced on Thursday, March 22nd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 22nd 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Ritter Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ritter Pharmaceuticals investors own include Endologix (ELGX) , Chipotle Mexican Grill (CMG) , Aegean Marine Petroleum Network (ANW) , Charles Schwab (SCHW) , Genocea Biosciences (GNCA) , Hudson Technologies (HDSN) , Vicor (VICR) , Zoetis (ZTS) and

When did Ritter Pharmaceuticals IPO?

Ritter Pharmaceuticals (RTTR) raised $20 million in an initial public offering on Wednesday, June 24th 2015. The company issued 4,000,000 shares at a price of $5.00 per share. Aegis Capital Corp and Chardan Capital Markets served as the underwriters for the IPO and Barrington Research was co-manager.

NASDAQ:RTTR

Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free RTTR Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.29
▼
$0.33
50-Day Range: $0.45
▼
$4.09
52-Week Range: $0.15
▼
$1.27

Volume: 27,054 shs
Average Volume: 14.23 million shs
Market Capitalization: $14.39 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Social Media

Get Ritter Pharmaceuticals alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Ritter Pharmaceuticals Stock (NASDAQ:RTTR)

Ritter Pharmaceuticals, Inc. develops and sells novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which has completed Phase 2b clinical trial for the reduction of symptoms associated with lactose intolerance. The company's product, RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon, thereby adapting the gut microbiome to assist in digesting the lactose that reaches the large intestine. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

RTTR Stock News Headlines

January 24, 2024 | health.usnews.com

Dr. John D. Ritter

September 15, 2023 | health.usnews.com

Kristen Ritter

April 18, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

July 8, 2023 | health.usnews.com

Dr. Harold K. Ritter

July 1, 2023 | bizjournals.com

Denver Business Journal welcomes new tech reporter

April 10, 2023 | usatoday.com

Jason Ritter and Drew Barrymore's raw conversation on her show may matter more than you think

March 29, 2023 | thestreet.com

Ritter Pharmaceuticals Changing the Game With Lactose Intolerance Treatment

March 18, 2023 | finance.yahoo.com

Global Microbiome Market Report 2023: Major Players Include MicroBiome Therapeutics, Seres Therapeutics, Enterome Bioscience and Second Genome

April 18, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

January 19, 2023 | yahoo.com

Melanie Lynskey's husband Jason Ritter will join her in Yellowjackets this season

November 16, 2022 | finance.yahoo.com

Microbiome Clinical Trial Pipeline Space Brims with Novel Emerging Therapies with 130+ Key Players Working in the Domain | DelveInsight

See More Headlines

Receive RTTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ritter Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/01/2020
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:RTTR
CUSIP: N/A
CIK: 1460702
Web: www.ritterpharmaceuticals.com
Phone: 310-203-1000
Fax: N/A
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,130,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -162.05%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.67
Quick Ratio: 3.67

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.10 per share
Price / Book: 3.12

Miscellaneous

Outstanding Shares: 46,153,000
Free Float: N/A
Market Cap: $14.39 million
Optionable: Not Optionable
Beta: -0.43

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Ira Eliot Ritter (Age 70)
Co-Founder, Exec. Chairman & Chief Strategic Officer
Mr. Andrew J. Ritter (Age 36)
Co-Founder, CEO, Pres, Corp. Sec. & Director
Mr. Michael D. Step (Age 59)
Consultant & Director
Mr. John W. Beck CPA (Age 59)
CPA, Chief Financial Officer
Ms. Ellen F. Mochizuki (Age 52)
Consultant

Key Competitors

View All Competitors

RTTR Stock Analysis - Frequently Asked Questions

How were Ritter Pharmaceuticals' earnings last quarter?: Ritter Pharmaceuticals Inc (NASDAQ:RTTR) issued its quarterly earnings data on Friday, May, 1st. The biotechnology company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.04) by $0.01.
When did Ritter Pharmaceuticals' stock split?: Ritter Pharmaceuticals shares reverse split on the morning of Friday, March 23rd 2018. The 1-10 reverse split was announced on Thursday, March 22nd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 22nd 2018. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
What other stocks do shareholders of Ritter Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ritter Pharmaceuticals investors own include Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Charles Schwab (SCHW), Genocea Biosciences (GNCA), Hudson Technologies (HDSN), Vicor (VICR), Zoetis (ZTS) and
When did Ritter Pharmaceuticals IPO?: Ritter Pharmaceuticals (RTTR) raised $20 million in an initial public offering on Wednesday, June 24th 2015. The company issued 4,000,000 shares at a price of $5.00 per share. Aegis Capital Corp and Chardan Capital Markets served as the underwriters for the IPO and Barrington Research was co-manager.

This page (NASDAQ:RTTR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis

About Ritter Pharmaceuticals Stock (NASDAQ:RTTR)

RTTR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

RTTR Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info